Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm

Clinical trial NCT00911300 · COMPLETED

Trial details

NCT number: NCT00911300
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fibrillation, Atrial

Start date: 2009-08-01
Primary completion: 2011-09-01
Enrollment: 349

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.